OVERSEA CHINESE BANKING Corp Ltd bought a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 11,290 shares of the financial services provider's stock, valued at approximately $931,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Carmichael Hill & Associates Inc. raised its holdings in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC raised its holdings in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after purchasing an additional 277 shares in the last quarter. Fortitude Family Office LLC raised its holdings in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock worth $34,000 after purchasing an additional 266 shares in the last quarter. Bank & Trust Co bought a new position in MetLife in the second quarter worth $39,000. Finally, Crewe Advisors LLC raised its holdings in MetLife by 602.5% in the second quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider's stock worth $39,000 after purchasing an additional 482 shares in the last quarter. Institutional investors own 89.81% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on MET shares. Jefferies Financial Group increased their price objective on MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a report on Friday, September 27th. Barclays cut their target price on MetLife from $91.00 to $90.00 and set an "overweight" rating on the stock in a research note on Thursday, October 31st. Citigroup increased their target price on MetLife from $83.00 to $89.00 and gave the stock a "buy" rating in a research note on Tuesday, July 23rd. Piper Sandler increased their target price on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 2nd. Finally, Morgan Stanley cut their target price on MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research note on Monday, August 19th. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, MetLife currently has a consensus rating of "Buy" and a consensus target price of $88.46.
Read Our Latest Report on MetLife
MetLife Price Performance
MET traded up $0.52 on Thursday, hitting $82.54. 1,125,233 shares of the company's stock traded hands, compared to its average volume of 3,318,557. The company's 50 day simple moving average is $81.30 and its 200-day simple moving average is $75.43. The firm has a market cap of $57.15 billion, a price-to-earnings ratio of 16.54, a P/E/G ratio of 0.75 and a beta of 1.05. MetLife, Inc. has a one year low of $61.61 and a one year high of $86.94. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date is Tuesday, November 5th. MetLife's payout ratio is 43.95%.
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.